NO911049L - Matrise med immun-modulerende aktivitet. - Google Patents

Matrise med immun-modulerende aktivitet.

Info

Publication number
NO911049L
NO911049L NO91911049A NO911049A NO911049L NO 911049 L NO911049 L NO 911049L NO 91911049 A NO91911049 A NO 91911049A NO 911049 A NO911049 A NO 911049A NO 911049 L NO911049 L NO 911049L
Authority
NO
Norway
Prior art keywords
matrix
saponin
adjuvants
modulative
immun
Prior art date
Application number
NO91911049A
Other languages
English (en)
Other versions
NO911049D0 (no
Inventor
Bror Morein
Karin Loevgren
Kristian Dalsgaard
Jan Thurin
Bo Sundquist
Original Assignee
Bror Morein
Karin Loevgren
Kristian Dalsgaard
Jan Thurin
Bo Sundquist
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8901027A external-priority patent/SE8901027D0/xx
Priority claimed from SE8902780A external-priority patent/SE8902780D0/xx
Priority claimed from PCT/SE1989/000528 external-priority patent/WO1990003184A1/en
Application filed by Bror Morein, Karin Loevgren, Kristian Dalsgaard, Jan Thurin, Bo Sundquist filed Critical Bror Morein
Publication of NO911049D0 publication Critical patent/NO911049D0/no
Publication of NO911049L publication Critical patent/NO911049L/no

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Iscom-matrise som Ikke er en lipidvesikkel omfattende minst ett llpid og minst en saponin uten tilsiktede antigenlske determinanter og eventuelt også adjuvants for anvendelse som et immunmodulerende middel, legemidler, vaksiner, klt som inneholder matrisen og nye saponlner, og en fremgangsmåte for fremstilling av nye saponlner, er beskrevet. Fremgangsmåten for fremstilling av matrisen kjennetegnet ved av minst en sterol blir oppløst i et oppløsningsmiddel eller en detergent, saponinen eller saponinene blir tilsatt, de andre adjuvantene og lipldene blir også eventuelt tilsatt, mens det organiske oppløsningsmidlet eller detergenten kan bli fjernet for eksempel ved dlalyse, ultraflltrerlng, gelfiltrerlng eller elektroforese, er også beskrevet. Sterolen og saponinen kan også bli oppløst i lipidene og/eller adjuvantene.
NO91911049A 1988-09-30 1991-03-15 Matrise med immun-modulerende aktivitet. NO911049L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25157688A 1988-09-30 1988-09-30
SE8901027A SE8901027D0 (sv) 1989-03-22 1989-03-22 Triterpenoider
SE8902780A SE8902780D0 (sv) 1989-08-16 1989-08-16 Corncerning qa-matrix
PCT/SE1989/000528 WO1990003184A1 (en) 1988-09-30 1989-09-28 Matrix with immunomodulating activity

Publications (2)

Publication Number Publication Date
NO911049D0 NO911049D0 (no) 1991-03-15
NO911049L true NO911049L (no) 1991-05-03

Family

ID=27484706

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91911049A NO911049L (no) 1988-09-30 1991-03-15 Matrise med immun-modulerende aktivitet.

Country Status (1)

Country Link
NO (1) NO911049L (no)

Also Published As

Publication number Publication date
NO911049D0 (no) 1991-03-15

Similar Documents

Publication Publication Date Title
ES2029758A6 (es) Proacedimiento para la fabricacion de una matriz con actividad inmunomodulora a partir de saponinas.
Melish et al. The staphylococcal scalded-skin syndrome: isolation and partial characterization of the exfoliative toxin
Nussenzweig et al. Specificity of protective immunity produced by x-irradiated Plasmodium berghei sporozoites
Comstock et al. Penetration of endothelial cell monolayers by Borrelia burgdorferi
SE8201351L (sv) Sett att framstella liposomberedningar
NO913518L (no) Vaksiner for ikke typebestembar haemophilus influenzae.
DE69423383D1 (de) Herstellung und Verwendungen von LOS-verminderten Aussenmembran-Proteinen von Gram-negativen Kokken
GR1000604B (el) Μεθοδος για την παρασκευη γλυκοσυλιωμενων ινσουλινων και συνδιασμων αυτων.
DE69027013T2 (de) Verfahren zur Reinigung eines 69000 Dalton antigenischen Proteins aus Bordetella pertussis
NO893504D0 (no) Fremgangsmaate for fremstilling av transdermalt anvendbarefarmasoeytiske preparater med steroliner og/eller spiroketaliner.
PT95190A (pt) Processo para a preparacao de um meio de contraste
PT88524A (pt) Process of preparation of a vaccine for the protection of birdsagainst contagions by mycoplasma and the preparation of a pure culture of the same
ZA784324B (en) High molecular weight meningococcal group c vaccine and method for preparation thereof
NO911049L (no) Matrise med immun-modulerende aktivitet.
DK365287D0 (da) Fremgangsmaade til dyrkning af bordetella pertussis, pertussis toxoid, pertussis vacciner og fremgangsmaade til fremstilling af pertussis vacciner
Chicurel et al. Modulation of macrophage lysosomal pH by Mycobacterium tuberculosis-derived proteins
Murphy et al. Cryptococcal culture filtrate antigen for detection of delayed-type hypersensitivity in cryptococcosis
Papermaster et al. Desensitization: II. Passive transfer of the desensitized state by serum from desensitized animals
US5045456A (en) Process for removing bacterial endotoxin from gram-negative polysaccharides
EP0090660A3 (en) Neisseria gonorrhoeae vaccine
Affronti et al. Some early investigations of Mycobacterium tuberculosis
NO913131L (no) Immunogene konjugater av ikke-toksisk oligosakkarid fra bordetella pertussis lipoolysakkarid.
CA1206904A (en) Antigen for detecting toxoplasmic immunity and the process for preparing same
Semprevivo Exometabolites of Leishmania donovani promastigotes. I. Isolation and initial characterization
McNeill The antibody response of rabbits to inactivated vaccinia virus